Inhibition of allergic inflammation in a murine model of asthma by expression of a dominant-negative mutant of GATA-3

Immunity

Volumn 11, Issue 4, 1999, Pages 473-482

  Zhang, Dong Hong ^a   Yang, Liyan ^a   Cohn, Lauren ^a   Parkyn, Lisa ^a   Homer, Robert ^a,b   Ray, Prabir ^a   Ray, Anuradha ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHILIA; GENE EXPRESSION; HELPER CELL; IMMUNOGLOBULIN PRODUCTION; INFLAMMATION; MOUSE; MUCUS SECRETION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

EID: 0033212806     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80122-3     Document Type: Article

References (61)

1. Alexander, J., Coombs, G.H., and Mottram, J.C. (1998). Leishmania mexicana cysteine proteinase-deficient mutants have attenuated virulence for mice and potentiate a Th1 response. J. Immunol. 161, 6794-6801.
2. Allen, J.M., Forbush, K.A., and Perlmutter, R.M. (1992). Functional dissection of the lck proximal promoter. Mol. Cell. Biol. 12, 2758-2768.
3. Brusselle, G.G., Kips, J.C., Joos, G., Bluethman, H., and Pauwels, R.A. (1995). Allergen-induced airway inflammation and bronchial responsiveness in wild-type and interleukin-4-deficient mice. Am. J. Respir. Cell. Mol. Biol. 12, 254-259.
4. Busse, W.W. (1998). Inflammation in asthma: The cornerstone of the disease and target of therapy. J. Allergy Clin. Immunol. 102, S17-S22.
5. Coffman, R.L., Seymour, B.W.P., Hudak, S., Jackson, J., and Rennick, D. (1989). Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science 245, 308-310.
6. Cohn, L., Homer, R.J., Marinov, A., Rankin, J., and Bottomly, K. (1997). Induction of airway mucus production by T helper 2 (Th2) cells: A critical role for interleukin-4 in cell recruitment but not mucus production. J. Exp. Med. 186, 1737-1747.
7. Cohn, L., Tepper, J.S., and Bottomly, K. (1998). Cutting edge: IL-4-independent induction of airway hyperresponsiveness by Th2, but not Th1, cells. J. Immunol. 161, 3813-3816.
8. Cohn, L., Homer, R.J., MacLeod, H., Mohrs, M., Brombacher, F., and Bottomly, K. (1999a). Th2-induced airway mucus production is dependent on IL-4Rα, but not on eosinophils. J. Immunol. 162, 6178-6183.
9. Cohn, L., Homer, R.J., Niu, N., and Bottomly, K. (1999b). Th1 cells and IFN-γ regulate allergic airway inflammation and mucus production. J. Exp. Med., in press.
10. Collins, P.D., Marleau, S., Griffiths-Johnson, D.A., Jose, P.J., and Williams, T.J. (1995). Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J. Exp. Med. 182, 1169-1174.
11. Corry, D.B., Folfesson, H.G., Warnock, M.L., Erle, D.J., Matthay, M.A., Wiener-Kronish, J.P., and Locksley, R.M. (1996). Interleukin-4, but not interleukin-5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J. Exp. Med. 183, 109-117.
12. De Monchy, J.G.R., Kaufmann, H.F., Venge, P., Koeter, G.H., Jansen, H.M., Sluiter, H.J., and De Vries, K. (1985). Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am. Rev. Respir. Dis. 131, 373-376.
13. Dent, L.A., Strath, M., Mellor, A.L., and Sanderson, C.J. (1990). Eosinophilia in transgenic mice expressing interleukin 5. J. Exp. Med. 172, 1425-1431.
14. Foster, P.S., Hogan, S.P., Ramsay, A.J., Matthaei, K.I., and Young, I.G. (1996). Interleukin-5 deficiency abolishes eosinophilia, airways hyperreactivity and lung damage in mouse asthma model. J. Exp. Med. 183, 195-201.
15. Frick, W.E., Sedgwick, J.B., and Busse, W.W. (1989). The appearance of hypodense eosinophils in antigen-dependent late phase asthma. Am. Rev. Respir. Dis. 139, 1401-1406.
16. George, K.M., Leonard, M.W., Roth, M.E., Lieuw, K.H., Kioussis, D., Grosveld, F., and Engel, J.D. (1994). Embryonic expression and cloning of the murine GATA-3 gene. Development 120, 2673-2686.
17. Gleich, G.J., and Kita, H. (1997). Bronchial asthma: Lessons from murine models. Proc. Natl. Acad. Sci. USA 94, 2101-2102.
18. Gleich, G.J., Flavahan, N.A., Fujisawa, T., and Vanhoutte, P.M. (1988). The eosinophil as a mediator of damage to respiratory epithelium: A model for bronchial hyperreactivity. J. Allergy Clin. Immunol. 81, 776-881.
19. Glimcher, L.H., and Singh, H. (1999). Transcription factors in lymphocyte development-T and B cells get together. Cell 96, 13-23.
20. Gossen, M., and Bujard, H. (1992). Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89, 5547-5551.
21. Gossen, M., Freundlieb, S., Bender, G., Muller, G., Hillen, W., and Bujard, H. (1995). Transcriptional activation by tetracyclinesin mammalian cells. Science 268, 1766-1769.
22. Grunig, G., Warnock, M., Wakil, A.E., Venkayya, R., Brombacher, F., Rennick, D.M., Sheppard, D., Mohrs, M., Donaldson, D.D., Locksley, R.M., and Corry, D.B. (1998). Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282, 2261-2263.
23. Hattori, N., Kawamoto, H., Fujimoto, S., Kuno, K., and Katsura, Y. (1996). Involvement of transcription factors TCF-1 and GATA-3 in the initiation of the earliest step of T cell development in the thymus. J. Exp. Med. 184, 1137-1147.
24. Ho, I.-C., Hodge, M.R., Rooney, J.W., and Glimcher, L.H. (1996). The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell 85, 973-983.
25. Ho, I.-C., Lo, D., and Glimcher, L.H. (1998). c-maf promotes T helper cell type 2 (Th2) and attenuates Th1 differentiation by both interleukin-4-dependent and -independent mechanisms. J. Exp. Med. 188, 1859-1866.
26. Holgate, S.T. (1997). Asthma: A dynamic disease of inflammation and repair. Ciba Found. Symp. 206, 5-28.
27. Kim, J.I., Ho, I.-C., Grusby, M.J., and Glimcher, L.H. (1999). The transcription factor c-Maf controls the production of IL-4 but not other Th2 cytokines. Immunity 10, 745-751.
28. Ko, L.J., and Engel, J.D. (1993). DNA-binding specificities of the GATA transcription factor family. Mol. Cell. Biol. 13, 4011-4022.
29. Kopf, M., Le Gros, G., Bachmann, M., Laemars, M.C., Bluethmann, H., and Kohler, G. (1993). Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362, 245-248.
30. + B-1 cells and lack eosinophils but have normal antibody and cytotoxic T cell responses. Immunity 4, 15-24.
31. Lee, H.J., O'Garra, A., Arai, K.-I., and Arai, N. (1998). Characterization of cis-regulatory elements and nuclear factors conferring Th2-specific expression of the IL-5 gene: A role for a GATA-binding protein. J. Immunol. 160, 2343-2352.
32. Lopez, A.F., Sanderson, C.J., Gamble, J.R., Campbell, H.D., Young, I.G., and Vadas, M.A. (1988). Recombinant human interleukin 5 is a selective activator of human eosinophil function. J. Exp. Med. 167, 219-224.
33. Maggi, E., and Romagnani, S. (1994). Role of T cells and T-cell-derived cytokines in the pathogenesis of allergic diseases. Ann. NY Acad. Sci. 725, 2-12.
34. McKenzie, G.J., Emson, C.L., Bell, S.E., Anderson, S., Fallon, P., Zurawski, G., Murray, R., Grencis, R., and McKenzie, A.N. (1998). Impaired development of Th2 cells in IL-13-deficient mice. Immunity 9, 423-432.
35. Morel, P.A., and Oriss, T.B. (1998). Crossregulation between Th1 and Th2 cells. Crit. Rev. Immunol. 18, 275-303.
36. Nakamura, Y., Ghaffar, O., Olivenstein, R., Taha, R.A., Soussi-Gounni, A., Zhang, D.-H., Ray, A., and Hamid, Q. (1999). Gene expression of the GATA-3 transcription factor is increased in atopic asthma. J. Allergy Clin. Immunol. 103, 215-222.
37. Northrop, J.P., Ho, S.N., Chen, L., Thomas, D.J., Timmerman, L.A., Nolan, G.P., Admon, A., and Crabtree, G.R. (1994). NF-AT components define a family of transcription factors targeted in T-cell activation. Nature 369, 497-502.
38. Orkin, S.H. (1992). GATA-binding transcription factors in hematopoietic cells. Blood 80, 575-581.
39. Ouyang, W., Ranganath, S.H., Weindel, K., Bhattacharya, D., MurPhy, T.L., Sha, W.C., and Murphy, K.M. (1998). Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity 9, 745-755.
40. Pandolfi, P., Roth, M.E., Karis, A., Leonard, M.W., Dzierzak, E., GrosVeld, F.G., Engel, J.D., and Lidenbaum, M.H. (1995). Target disruption of the GATA-3 gene causes severe abnormalities in the nervous system and in fetal liver hematopoiesis. Nat. Genet. 11, 40-44.
41. Perez, P., Lira, S.A., and Bravo, R. (1995). Overexpression of RelA in transgenic mouse thymocytes: Specific increase in level of the inhibitor protein IκBα. Mol. Cell. Biol. 15, 3523-3530.
42. Phipps, R.P., Stein, S.H., and Roper, R.L. (1991). A new view of prostaglandin E regulation of the immune response. Immunol. Today 12, 349-352.
43. Ranganath, S., Ouyang, W., Bhattacharya, D., Sha, W.C., Grupe, A., Peltz, G., and Murphy, K.M. (1998). Cutting edge: Gata-3-dependent enhancer activity in IL-4 gene regulation. J. Immunol. 161, 3822-3826.
44. Ranger, A.M., Hodge, M.R., Gravallese, E.M., Oukka, M., Davidson, L., Alt, F.W., De La Brousse, F.C., Hoey, T., Grusby, M., and Glimcher, L.H. (1998). Delayed lymphoid repopulation with defects in IL-4-driven responses produced by inactivation of NF-ATc. Immunity 8, 125-134.
45. Ray, P., Tang, W.L., Wang, P., Homer, R., Kuhn III, C., Flavell, R.A., and Elias, J.A. (1997). Regulated overexpression of interleukin 11 in the lung: Use to dissociate development-dependent and -independent phenotypes. J. Clin. Invest. 100, 2501-2511.
46. H2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326, 298-304.
47. Seder, R.A., and Paul, W.E. (1994). Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu. Rev. Immunol. 12, 635-673.
48. Siegel, M.D., Zhang, D.-H., Ray, P., and Ray, A. (1995). Activation of the interleukin-5 promoter by cAMP in murine EL-4 cells requires the GATA-3 and CLE0 elements. J. Biol. Chem. 270, 24548-24555.
49. Smith, V.M., Lee, P.P., Szychowski, S., and Winoto, A. (1995). GATA-3 dominant negative mutant. J. Biol. Chem. 270, 1515-1520.
50. Snijdewint, F.G.M., Kalinski, P., Wierenga, E.A., Bos, J.D., and Kapsenberg, M.L. (1993). Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J. Immunol. 150, 5321-5329.
51. Ting, C.-N., Olson, M.C., Barton, K.P., and Leiden, J.M. (1996). Transcription factor GATA-3 is required for development of the T-cell lineage. Nature 384, 474-478.
52. Umetsu, D.T., and DeKruyff, R.H. (1997). Th1 and Th2 CD4+ T cells in the pathogenesis of allergic diseases. Proc. Soc. Exp. Biol. Med. 215, 11-20.
53. Wills-Karp, M. (1999). Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol. 17, 255-281.
54. Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T.Y., Karp, C.L., and Donaldson, D.D. (1998). Interleukin-13: Central mediator of allergic asthma. Science 282, 2258-2261.
55. Yamaguchi, Y., Suda, T., Shiozaki, H., Miura, Y., Hitoshi, Y., TomiNaga, A., Takatsu, K., and Kasahara, T. (1990). Role of IL-5 in IL-2-induced eosinophilia: In vivo and in vitro expression of IL-5 mRNA by IL-2. J. Immunol. 145, 873-877.
56. Yang, L., Cohn, L., Zhang, D.-H., Homer, R., Ray, A., and Ray, P. (1998). Essential role of nuclear factor κB in the induction of eosinophilia in allergic airway inflammation. J. Exp. Med. 188, 1739-1750.
57. Yoshida, H., Nishina, H., Takimoto, H., Marengere, L.E., Wakeham, A.C., Bouchard, D., Kong, Y.Y., Ohteki, T., Shahinian, A., Bachmann, M., et al. (1998). The transcription factor NF-ATc1 regulates lymphocyte proliferation and Th2 cytokine production. Immunity 8, 115-124.
58. Youn, J., Chen, J., Goenka, S., Aronica, M.A., Mora, A.L., Correa, V., Sheller, J.R., and Boothby, M. (1998). In vivo functio of an interleukin 2 receptor β chain (IL-2Rβ)/IL-4Rα cytokine receptor chimera potentiates allergic airway disease. J. Exp. Med. 188, 1803-1816.
59. Zhang, D.-H., Cohn, L., Ray, P., Bottomly, K., and Ray, A. (1997). Transcription factor GATA-3 is differentially expressed in Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J. Biol. Chem. 272, 21597-21603.
60. Zhang, D.-H., Yang, L., and Ray, A. (1998). Cutting edge: Differential responsiveness of the interleukin-5 (IL-5) and IL-4 genes to transcription factor GATA-3. J. Immunol. 161, 3817-3821.
61. Zheng, W.-P., and Flavell, R.A. (1997). The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89, 587-596.